• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » J&J EVP, general counsel Michael Ullmann set to retire

J&J EVP, general counsel Michael Ullmann set to retire

July 18, 2022 By Sean Whooley

johnson & johnson logoJohnson & Johnson (NYSE:JNJ) announced today that, after 33 years, Michael Ullmann will retire as EVP and general counsel.

Ullmann’s retirement will be made effective on Oct. 17, 2022, at which point Elizabeth Forminard will succeed him as EVP and general counsel, as well as take up a position as a member of Johnson & Johnson’s executive committee.

New Brunswick, New Jersey-based Johnson & Johnson said in a news release that Ullann and Forminard will work together during a transition period until the former’s retirement.

Ullmann joined the company as a mergers and acquisitions attorney in 1989 and has held positions of increasing responsibility since, serving as general counsel for the past 11 years. He also served as the executive sponsor for J&J’s Hispanic and Latino employee resource group and as a member of the Leadership Council on Legal Diversity, an organization that works to build a more open and diverse legal profession.

“For three decades, Mike set the standard for credo leadership at the company. I thank him for his unwavering commitment to help deliver on Our Purpose of advancing health for humanity,” Johnson & Johnson CEO Joaquin Duato said in the release. “Throughout his tenure, Mike has guided the company through an evolving global environment with respect and clarity, always keeping our patients and customers at the center of all decisions.”

Forminard has been with Johnson & Johnson for 16 years and served as general counsel across its pharmaceutical, consumer health and medtech sectors. She was also worldwide VP leading the corporate governance function.

Most recently, she served as general counsel for the pharmaceuticals legal group and a member of the pharmaceuticals group operating committee.

“I’m thrilled to appoint Liz to this important role and will lean on her strong business acumen and understanding of patient and customer needs during this pivotal time at our Company,” Duato said. “I’m confident her distinguished experience and leadership will help us find new pathways to bring innovative healthcare solutions to those in need all over the world.”

Filed Under: Business/Financial News, Featured, News Well Tagged With: Johnson & Johnson, Personnel Moves

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy